Open-Label Study of AG10 in Patients with Cardiomyopathy

NCT03536767 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyloid Cardiomyopathy

Interventions

DRUG: AG10

Sponsor

Eidos Therapeutics, a BridgeBio company